We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Emily Gallagher

Emily J. Gallagher MD

Assistant Professor of Medicine, Endocrinology, Diabetes and Bone Disease; Associate Program Director for Research; Director of the Research Track for the Internal Medicine Residency Program, Icahn School of Medicine at Mount Sinai, New York, New York

Dr. Emily J. Gallagher is Assistant Professor of Medicine, Endocrinology, Diabetes and Bone Disease, Associate Program Director for Research, and Director of the Research Track for the Internal Medicine Residency Program. She is an NIH-funded physician-scientist and onco-endocrinologist at the Icahn School of Medicine at Mount Sinai, New York. Her research relates to understanding the links between the metabolic syndrome and cancer, specifically the roles of insulin and lipids in cancer development and progression. She is also a clinical onco-endocrinologist, treating the metabolic and endocrine consequences of cancer, and cancer therapies.

Disclosures

Dr. Gallagher is on the advisory board for Novartis and does consulting for Seagen and SynDevRx.

Recent Contributions to PracticeUpdate:

  1. Obesity and Cancer Death by Race